Jianmin Pharmaceutical Group Co Ltd (600976) — Cash Flow Reinvestment Rate
Jianmin Pharmaceutical Group Co Ltd (600976) has a Cash Flow Reinvestment Rate of 0.36x as of December 2025, reinvesting CN¥38.21 Million (capex CN¥23.23 Million plus investments CN¥-14.98 Million) from operating cash flow of CN¥106.82 Million. Explore reinvestment intensity of Jianmin Pharmaceutical Group Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jianmin Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Jianmin Pharmaceutical Group Co Ltd across 20 annual periods. Also explore 600976 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Jianmin Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see Jianmin Pharmaceutical Group Co Ltd (600976) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥114.34 Million | CN¥274.53 Million | CN¥100.67 Million | ▼ -70.2% |
| 2024 | 1.40x | CN¥327.06 Million | CN¥234.27 Million | CN¥120.29 Million | ▲ +164.2% |
| 2023 | 0.53x | CN¥141.81 Million | CN¥268.39 Million | CN¥64.50 Million | ▼ -20.5% |
| 2022 | 0.66x | CN¥143.44 Million | CN¥215.87 Million | CN¥67.96 Million | ▲ +45.5% |
| 2021 | 0.46x | CN¥118.37 Million | CN¥259.18 Million | CN¥55.99 Million | ▼ -67.0% |
| 2020 | 1.38x | CN¥173.75 Million | CN¥125.54 Million | CN¥45.58 Million | ▼ -28.2% |
| 2019 | 1.93x | CN¥143.57 Million | CN¥74.45 Million | CN¥69.31 Million | ▼ -10.4% |
| 2018 | 2.15x | CN¥136.82 Million | CN¥63.60 Million | CN¥42.37 Million | ▼ -62.3% |
| 2017 | 5.71x | CN¥200.93 Million | CN¥35.20 Million | CN¥41.93 Million | ▲ +448.5% |
| 2016 | 1.04x | CN¥118.48 Million | CN¥113.84 Million | CN¥29.42 Million | ▼ -51.3% |
| 2015 | 2.14x | CN¥103.55 Million | CN¥48.45 Million | CN¥29.75 Million | ▲ +724.1% |
| 2014 | 0.26x | CN¥26.77 Million | CN¥103.23 Million | CN¥26.77 Million | ▼ -50.8% |
| 2013 | 0.53x | CN¥23.90 Million | CN¥45.36 Million | CN¥23.90 Million | ▲ +476.8% |
| 2012 | 0.09x | CN¥8.97 Million | CN¥98.17 Million | CN¥8.97 Million | ▲ +153.3% |
| 2010 | 0.04x | CN¥5.41 Million | CN¥150.08 Million | CN¥5.41 Million | ▼ -83.4% |
| 2009 | 0.22x | CN¥14.50 Million | CN¥66.69 Million | CN¥14.50 Million | ▲ +175.5% |
| 2008 | 0.08x | CN¥8.69 Million | CN¥110.11 Million | CN¥8.69 Million | ▼ -73.3% |
| 2006 | 0.30x | CN¥16.61 Million | CN¥56.18 Million | CN¥16.61 Million | ▼ -97.9% |
| 2004 | 13.95x | CN¥57.64 Million | CN¥4.13 Million | CN¥57.64 Million | ▼ -40.3% |
| 2003 | 23.37x | CN¥97.88 Million | CN¥4.19 Million | CN¥97.88 Million | — |